Skip to main content
OpenTrials
Completed

NCT Number: NCT00459459

Prognostic Significance of Fine-Needle Aspiration Cytology Features in Papillary Thyroid Carcinoma

The purpose of this study is to investigate the relationship between prognosis and fine needle aspiration cytology character of papillary thyroid cancer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Shyang-Rong, Shih

Dou-Liou City, Yun-Lin County, Taiwan

About this study

Papillary thyroid carcinoma is the most common thyroid malignancy worldwide. The influence of clinicopathologic features on prognosis has been examined, but the relationship between cytologic features obtained by fine-needle aspiration (FNA) and prognosis has been minimally studied. We retrospectively studied the cytologic features with computerized morphometry in 83 patients with usual-type papillary thyroid cancer and followed them for more than 10 years except for one with metastasis at diagnosis. The cytologic features of FNA and recurrence of cancer were examined statistically.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Papillary thyroid cancer diagnosed in NTUH from 1977 to 2000

Exclusion criteria

  • Patient without complete medical record

Treatment and study plan

Fine needle aspiration of the thyroid

Procedure

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Important dates

Study start
2006
Study completion
2006
First posted
Apr 12, 2007
Registry last updated
Apr 12, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.